ASCO Interview 2013: Matthias Holdhoff discusses his presentation on primary CNS lymphoma
Matthias Holdhoff, MD, PHD, Assistant Professor of Oncology. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Matthias Holdhoff, MD, PHD, Assistant Professor of Oncology. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.
CHICAGO – Five pivotal studies were released today ahead of the plenary session of the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
by Jamie Von Roenn, MD, and Charles von Gunten, MD, PhD – The call to integrate palliative care practices and principles into comprehensive cancer care, not as something… read more.
The American Society of Clinical Oncology (ASCO) kicked off its 49th Annual Meeting with leaders urging all stakeholders in cancer care to vigorously oppose cuts to vital US… read more.
CHICAGO – The American Society of Clinical Oncology (ASCO) has completed the first phase in developing several sets of interoperability standards for cancer care data and overcoming the… read more.
CHICAGO – New advances against melanoma, ovarian cancer, and colorectal cancer care were presented today at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)…. read more.
by Bruce Sylvester – Patients with an advanced kind of lung cancer and a dysfunctional ALK gene have achieved better outcomes with the targeted investigative therapy crizotinib rather… read more.
by Bruce Sylvester – European Organisation for the Research and Treatment of Cancer (EORTC) researchers from the AMAROS (After Mapping of the Axilla: Radiotherapy Or Surgery?) trial reported… read more.
Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.
by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study.